DSG3 and acquired polycythemia vera: On the other hand, the fact that an intermolecular ES from Dsg3 to Dsg1 and not the presence of cross-reactive antibodies is at the base of clinical phenotype transition in PV was demonstrated by an inhibition assay in PV patients with mucocutaneous lesions (67).